Title: Fanny Mann - Innovator in Cancer Treatment
Introduction: Fanny Mann is an inventor based in La Ciotat, France. He has made significant contributions to the field of cancer treatment through his research and innovative ideas. Although he currently holds no granted patents, his work is noteworthy and impactful.
Latest Patent Applications: Fanny Mann's latest patent application is titled "Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents." This invention focuses on the treatment of certain cancers using antagonists that inhibit the binding between Plexin and Sema3E. The application highlights the potential for treating primary cancer cell development and metastasis, particularly in cases where Sema3E is overexpressed by tumoral cells or the stroma. The invention addresses various types of cancer, including breast cancer with distant metastases, prostate cancer, melanoma, and glioblastoma. The proposed antagonists may include any molecule that specifically binds to PlexinD1 or Sema3E, effectively blocking their interaction. In some embodiments, the antagonist may be a polypeptide or an antibody.
Conclusion: Fanny Mann's innovative approach to cancer treatment through his research on Sema3E and PlexinD1 interactions showcases his dedication to advancing medical science. His contributions, although not yet patented, hold promise for future developments in oncology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.